Clinical Research Directory

Inclusion Criteria: * Participant is over 18 years of age at the time of signing the informed consent form. * Participant is able and willing to sign an informed consent form. * Participant is suspected by a provider of being at risk for developing cancer, OR * Participant has confirmed or clinically suspected malignancy by a provider. This includes but is not limited to: 1. Participants who may be candidates for or are scheduled to receive standard of care immunotherapy treatment for the first time for their current cancer diagnosis, regardless of any prior non-immunotherapy treatment. 2. Participants who are enrolled in a clinical trial to receive an investigational, novel immunotherapy drug for the first time for their current cancer diagnosis. 3. Participants who may be surgical candidates for their current cancer diagnosis, regardless of any prior treatment. Exclusion Criteria: * Participant is unable or unwilling to donate blood. * Concurrent medical or psychiatric condition or disease that may compromise the ability to give documented informed consent, is likely to interfere with study procedures or results, or that in the opinion of the investigator would constitute a hazard for participating in this study.